1783
vs
T
Taiwan Weighted Index
1783
Over the past 12 months, Maxigen Biotech Inc has underperformed Taiwan Weighted Index, delivering a return of -10% compared to the Taiwan Weighted Index's +20% growth.
Stocks Performance
1783 vs Taiwan Weighted Index
Performance Gap
1783 vs Taiwan Weighted Index
Performance By Year
1783 vs Taiwan Weighted Index
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Maxigen Biotech Inc
Glance View
Maxigen Biotech, Inc. engages in the research, development, manufacturing, and sales of biomedical materials and beauty care products. The company is headquartered in Taoyuan, Taoyuan. The company went IPO on 2011-05-18. The firm operates through two main segments. The Consumer Products segment is mainly engaged in the wholesales of cleansing products, facial care products, medical beauty products and others. The Biomedical Products is mainly involved in the manufacture and sales of Formagraft collagen and ceramic composite material products, Foramic ceramic bone feed materials, Artiaid hyaluronic acid joint injection products, ViscAid ophthalmology viscoelastic agents, as well as SurgiAid wound collagen materials and others.